A first‐in‐human study of DS‐1040, an inhibitor of the activated form of thrombin‐activatable fibrinolysis inhibitor, in healthy subjects
J. Zhou; J. Kochan; O. Yin; V. Warren; C. Zamora; G. Atiee; J. Pav; Y. Orihashi; V. Vashi; V. Dishy
Author Information: Daiichi Sankyo Pharma Development
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.